X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (242) 242
Patent (4) 4
Book Chapter (2) 2
Dissertation (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (97) 97
oncology (54) 54
female (42) 42
cancer (41) 41
male (39) 39
middle aged (37) 37
hematology (35) 35
cell biology (30) 30
adult (29) 29
animals (28) 28
aged (27) 27
cell line, tumor (21) 21
leukemia (20) 20
cell cycle (19) 19
aged, 80 and over (16) 16
centrosome - metabolism (16) 16
leukemia, myeloid, acute - genetics (16) 16
mutation (16) 16
diagnosis (15) 15
treatment outcome (15) 15
chemotherapy (14) 14
leukemia, myeloid, acute - drug therapy (14) 14
medicine & public health (14) 14
mitosis (13) 13
analysis (12) 12
cells (12) 12
chromosomal instability (12) 12
mice (12) 12
prognosis (12) 12
proteins (12) 12
research (12) 12
tumors (12) 12
acute myeloid-leukemia (11) 11
aneuploidy (11) 11
centrosome (11) 11
chromosome aberrations (11) 11
risk factors (11) 11
acute myeloid leukemia (10) 10
aml (10) 10
amplification (10) 10
antineoplastic agents - pharmacology (10) 10
apoptosis (10) 10
cell line (10) 10
signal transduction (10) 10
cell division (9) 9
chromosomes (9) 9
genomic instability (9) 9
instability (9) 9
leukemia, myeloid, acute - mortality (9) 9
medical prognosis (9) 9
protein (9) 9
stem cells (9) 9
biology (8) 8
bone marrow (8) 8
clinical trials (8) 8
health aspects (8) 8
patients (8) 8
phosphorylation (8) 8
transplantation (8) 8
aberrations (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
aurora-a (7) 7
biochemistry & molecular biology (7) 7
carcinoma (7) 7
cell proliferation (7) 7
centrosome - physiology (7) 7
centrosomes (7) 7
cycle (7) 7
disease-free survival (7) 7
dna-damage (7) 7
expression (7) 7
flow cytometry (7) 7
genetic aspects (7) 7
life sciences (7) 7
mutations (7) 7
neoplasms - genetics (7) 7
young adult (7) 7
abnormalities (6) 6
acute myelogenous leukemia (6) 6
apoptosis - drug effects (6) 6
binding (6) 6
care and treatment (6) 6
centrosome - drug effects (6) 6
checkpoint kinase 1 (6) 6
disease progression (6) 6
dna damage (6) 6
gene expression (6) 6
hemic and lymphatic diseases (6) 6
kinases (6) 6
medicine, general & internal (6) 6
multiple myeloma (6) 6
myelodysplastic syndrome (6) 6
neoplasms - pathology (6) 6
oncology, experimental (6) 6
primary site (6) 6
stem-cell transplantation (6) 6
survival (6) 6
therapy (6) 6
abridged index medicus (5) 5
age factors (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1691 - 1699
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the... 
Hematology, Oncology and Palliative Medicine | AML | ONCOLOGY | ACUTE MYELOGENOUS LEUKEMIA | BONE-MARROW | CLASSIFICATION | FLT3 MUTATIONS | CYTARABINE | STEM-CELL TRANSPLANTATION | COMBINATION | ELDERLY-PATIENTS | CHEMOTHERAPY | Niacinamide - analogs & derivatives | Recurrence | Age Factors | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Transplantation, Homologous | Neoadjuvant Therapy - mortality | Time Factors | Phenylurea Compounds - adverse effects | Leukemia, Myeloid, Acute - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Daunorubicin - therapeutic use | Double-Blind Method | Risk Factors | Kaplan-Meier Estimate | Niacinamide - adverse effects | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Disease Progression | Leukemia, Myeloid, Acute - mortality | Disease-Free Survival | Antimetabolites, Antineoplastic - therapeutic use | Leukemia, Myeloid, Acute - diagnosis | Antibiotics, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoadjuvant Therapy - adverse effects | Protein Kinase Inhibitors - therapeutic use | Germany | Antimitotic agents | Clinical trials | Chemotherapy | Antineoplastic agents | Standards | Cancer
Journal Article
Frontiers in oncology, ISSN 2234-943X, 2019, Volume 9, Issue MAY, p. 402
Journal Article
Nature medicine, ISSN 1546-170X, 2010, Volume 16, Issue 2, pp. 198 - 204
Journal Article